Vident Advisory, LLC Pacira Bio Sciences, Inc. Transaction History
Vident Advisory, LLC
- $10.5 Trillion
- Q3 2025
A detailed history of Vident Advisory, LLC transactions in Pacira Bio Sciences, Inc. stock. As of the latest transaction made, Vident Advisory, LLC holds 20,496 shares of PCRX stock, worth $487,394. This represents 0.01% of its overall portfolio holdings.
Number of Shares
20,496
Previous 18,241
12.36%
Holding current value
$487,394
Previous $436 Million
21.15%
% of portfolio
0.01%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding PCRX
# of Institutions
260Shares Held
48.9MCall Options Held
118KPut Options Held
63.7K-
Black Rock Inc. New York, NY8.01MShares$190 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.2MShares$124 Million0.0% of portfolio
-
Doma Perpetual Capital Management LLC Miami, FL2.7MShares$64.2 Million23.38% of portfolio
-
Dimensional Fund Advisors LP Austin, TX2.16MShares$51.4 Million0.01% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny2.14MShares$50.8 Million0.08% of portfolio
About Pacira BioSciences, Inc.
- Ticker PCRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 45,824,200
- Market Cap $1.09B
- Description
- Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid ...